Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
28 12월 2023 - 7:00PM
Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical
technology growth company, today announced that its management team
will meet with investors at the 42nd Annual J.P. Morgan
Healthcare Conference with a presentation scheduled for Monday,
January 8th, 2024, at 9:45 a.m. PST (12:45 p.m. EST). A link to the
live audio webcast, as well as a replay of this event, will be
available on the company’s website at Events and
Presentations.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an
innovation-driven medical technology growth company dedicated to
developing clinically differentiated solutions that generate
measurably better patient outcomes and transform workflows. Powered
by a culture of continuous improvement, global talent and
innovation, the Company’s extensive range of products, services and
integrated technologies fuels active lifestyles in orthopedics and
beyond. The Company’s shares of common stock are listed in the
United States on the New York Stock Exchange under the symbol
ENOV. For more information about Enovis, please visit
www.enovis.com.
Contact:
Kyle RoseVice President, Investor RelationsEnovis
Corporation+1-917-734-7450investorrelations@enovis.com
Enovis (NYSE:ENOV)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Enovis (NYSE:ENOV)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024